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Adventitial Fibroblast Abormality in Thoracic Aortic Aneurysms and 
Aortic Dissections 
Jong  Hui  Suh,  M.D.*,  Jeong-Seob  Yoon,  M.D.*,  Hwan  Wook  Kim,  M.D. * * ,  K e o n  H y o n  J o ,  M . D . * *
Background:  Development of thoracic aortic aneurysms and aortic dissections (TAAD) is attributed to unbearable 
wall tension superimposed on defective aortic wall integrity and impaired aortic repair mechanisms. Central to this 
repair mechanisms are well-balanced and adequately functional cellular components of the aortic wall, including en-
dothelial cells, smooth muscle cells (SMCs), inflammatory cells, and adventitial fibroblasts. Adventitial fibroblasts nat-
urally produce aortic extracellular matrix (ECM), and, when aortic wall is injured, they can be transformed into 
SMCs, which in turn are involved in aortic remodeling. We postulated the hypothesis that adventitial fibroblasts in 
patients with TAAD may have defects in ECM production and SMC transformation. Materials and Methods: 
Adventitial fibroblasts were procured from the adventitial layer of fresh aortic tissues of patients with TAAD (Group 
I) and of multi-organ donors (Group II), and 4-passage cell culture was performed prior to the experiment. To as-
sess ECM production, cells were treated with TNF-α (50 pM) and the expression of MMP-2 / MMP-3 was ana-
lyzed using western blot technique. To assess SMC transformation capacity, cells were treated with TGF-β1 and 
expression of SM α-actin, SM-MHC, Ki-67 and SM calponin was evaluated using western blot technique. 
Fibroblasts were then treated with TGF-β1 (10 pM) for up to 10 days with TGF-β1 supplementation every 2 
days, and the proportion of transformed SMC in the cell line was measured using immunofluorescence assay for 
fibroblast surface antigen every 2 days. Results: MMP-3 expression was significantly lower in group I than in 
group II. TGF-β1-stimulated adventitial fibroblasts in group I expressed less SM α-actin, SM-MHC, and Ki-67 
than in group II. SM-calponin expression was not different between the two groups. Presence of fibroblast was ob-
served on immunofluorescence assay after more than 6 days of TGF-β1 treatment in group I, while most fibro-
blasts were transformed to SMC within 4 days in group II. Conclusion: ECM production and SMC transformation 
are compromised in adventitial fibroblasts from patients with TAAD. This result suggests that functional restoration 
of adventitial fibroblasts could well be a novel approach for the prevention and treatment of TAAD.
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Table 1. Characteristics of the patients with thoracic aortic aneur-
ysm and dissection
    No Age Sex Diagnosis
  1 66 M Ascending  aortic  aneurysm 
  2 52 M Ascending  aortic  aneurysm 
  3 65 F DeBakey  type  I  dissection
  4 68 M Ascending  aortic  aneurysm 
  5 60 M DeBakey  type  I  dissection 
  6 55 M Ascending  aortic  aneurysm 
  7 40 M Descending  aortic  aneurysm 
  8 51 M DeBakey  type  II  dissection 
  9 69 F DeBakey  type  II  dissection
10 45 M DeBakey  type  I  dissection
INTRODUCTION
Although  thoracic  aortic  aneurysm  and  aortic  dissection 
(TAAD)  is  relatively  uncommon  compared  to  other  vascular 
diseases,  clinical  implications  of  this  disease  entity  are  of  ut-
most  significance  in  that  proper  management  in  a  timely 
fashion  is  the  key  to  a  successful  outcome.  Without  treat-
ment, spontaneous rupture occurs in 70% of the patients, and, 
once  develops,  would  reportedly  lead  to  94%  of  mortality. 
Surgical  intervention  is  known  to  be  the  most  effective  treat-
ment  modality,  but  most  of  the  victims  of  TAAD  are  ex-
posed  to  the  risk  of  detrimental  complications  caused  by  dis-
ease progression. Delay in treatment may be caused either by 
delay  in  diagnosis  or  by  bias  towards  improper  conservative 
treatment  based  on  the  poor  understanding  of  this  condition. 
Genetic  predisposition,  regression,  inflammation,  arthero-
sclerotic  changes  and  aortic  injury  by  toxic  materials  have 
been  proposed  to  be  the  pathogenesis  of  the  development  of 
TAAD [1,2]. Although these etiologies would have individual 
molecular biologic mechanisms [3], progressive destruction of 
the  aortic  wall  with  inflammatory  response  and  smooth  mus-
cle cell loss are the common features observed in the disease 
process  [4].  Thus,  it  is  prudent  to  state  that  the  development 
of  TAAD  is  attributed  to  unbearable  wall  tension  super-
imposed on defective aortic wall integrity and impaired aortic 
repair  mechanisms.  Central  to  this  repair  mechanisms  are 
well-balanced  and  adequately  functional  cellular  components 
of  the  aortic  wall,  including  endothelial  cells,  smooth  muscle 
cells  (SMCs),  inflammatory  cells,  and  adventitial  fibroblasts. 
While the roles of former three cell types in the development 
of  TAAD  are  relatively  well  known,  information  regarding 
adventitial fibroblast is sparse. Adventitial fibroblasts naturally 
produce  aortic  extracellular  matrix  (ECM),  and,  when  aortic 
wall  is  injured,  they  migrate  intro  aortic  media  and  can  be 
t r a n s f o r m e d  i n t o  S M C s ,  w h i c h  i n  t u r n  a r e  i n v o l v e d  i n  a o r t i c  
remodeling.  We  postulated  the  hypothesis  that  adventitial  fi-
broblasts  in  patients  with  TAAD  may  have  defects  in  ECM 
production  and  SMC  transformation.  To  test  this  hypothesis, 
we  compared  the  functional  characteristics  of  the  fibrobasts 
from  the  patients  with  TAAD  to  those  from  normal  subjects.   
MATERIALS AND METHODS
1) Fibroblast cell culture
Fresh  aortic  tissue  was  procured  from  10  patients  with 
TAAD (group I) and 10 cardiac transplantation donors (group 
II).  Age  at  operation  in  TAAD  group  was  57.1±10.1  years 
(40∼69  years)  (Table  1).  Specimens  were  stored  in  culture 
media  (DMEN,  invitrogen,  CA,  USA)  at  4
oC  for  less  than  4 
hours prior to  the next step. Adventitial  layer was  then sepa-
rated from the aortic wall, rinsed with the same culture media 
for  three  times,  minced  into  small  pieces,  and  stored  in  the 
culture  media  containing  5%  of  collagenase  and  elastinase  at 
37
oC  for  30  minutes.  Precipitates  separated  from  culture  me-
dia  using  centrifuge  were  then  cultured  in  10%  fetal  bovine 
serum  containing  antibiotics  (100  U/mL  of  penicillin)  in  an 
incubator with 5% CO2 at 37°C. Fresh culture media were re-
placed  every  48  hours, and,  every  4  to 7  days, cultured  cells 
were transferred to a new media for next-passage cell culture, 
to  finally  obtain  4-passage  cell  line. 
2) Western blot analysis
To  assess  the  extracellular  matrix  production  of  adventitial 
fibroblast,  cultured  cells  were  treated  with  TNF-α (Tumor 
n e c r o s i s  f a c t o r )  ( 5 0  p M ,  A B C a m ,  M A )  f o r  2  d a y s ,  r i n s e d  
with  PBS  for  three  times,  and  set  to  react  with  SDS  sample 
buffer (Tris-Cl, SDS, b-mercaptoethanol, Glycerol, Bromophe-
nol Blue) for 2∼3 minutes. Degeneration of the proteins was 
induced  by  heating  the  sample  for  5  to  10  minutes,  and  the 
sample  was  centrifuged  and  stored  in  the  ice.  Supernatant  of Jong Hui Suh, et al
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the sample (15 μL) was then processed by 10% SDS-polya-
crylamide  gel  electrophoresis ( S D S - P A G E ) ,  t r e a t e d  w i t h  
blocking  buffer  (5%  skim  milk)  for  2  hours  in  the  poly-
vinylidene fluoride (PVDF), and rinsed in the rinsing solution 
for  3  times.  The  reactor  of  this  protein,  matrix  metal-
loproteinase 2, 3 (MMP-2, MMP-3, ABCam, MA) antibodies, 
was  diluted  to  1 : 1,000,  and  stored  in  the  blocking  buffer  at 
4
oC  for  24  hours.  Then,  enhanced  Chemiluminescence  (ECL, 
Amersham  Biosciences,  NJ)  was  performed  using  the  protein 
and  the  reactor.  To  assess  the  degree  of  SMC  transformation 
of  the  fibroblasts,  cultured  cells  were  treated  with  TGFβ1 
(10 pM, ABCam, MA) for 2 days, and the remaining process 
was  the  same  as  above  except  for  that  reactors  were  for 
smooth muscle (SM) α-actin, SM-MHC, Ki-67, and SM cal-
ponin  (ABCam,  MA).
3) Immunofluorescent staining
To  conduct  an  in  vivo  test  to  assess  SMC  transformation 
of  the  fibroblasts,  each  fibroblast  was  placed  in  the  round 
culture  bottle,  and  TGFβ1  (10  pM,  ABCam,  MA)  was  sup-
plemented  every  2  days.  Cell  lines  were  observed  at  0,  2,  4, 
6,  8  and  10  days  after  the  treatment  of  TGFβ1  to  ascertain 
the  proportion  of  transformed  SMC  from  fibroblasts  using 
immunofluorescence  staining.  For  immunofluorescence  stain-
ing,  cu ltur e med ia w as elim in ated  from the culture plate,  and 
the  precipitates  were  rinsed  using  PBS  for  3  times.  Fixation 
of the cells was performed using 3.7% formaldehyde, and the 
cells  were  then  rinsed  with  PBS,  methanol,  0.5%  triton 
X-100T  and  1%  blocking  solution.  Antibodies  for  SM  α
-actin  and  fibroblast  surface  antigens  were  diluted  (1 : 1,000) 
and  stored  with  the  cells  at  4
oC  in  the  dark  room  overnight. 
The  cells  were  then  rinsed  with  PBS  to  react  with  Texas 
red-labeled  secondary  antibodies  (1 : 2,500)  for  1  hour  in  the 
dark  room,  and  subsequently  to  react  with  DAPI  (5  mg/mL) 
for  5  seconds  in  the  room  temperature.  After  the  cells  were 
rinsed by PBS, SMCs transformed from adventitial fibroblasts 
were  observed  using  immunofluorescent  microscopy  (Leica 
MPS  60,  Germany).
4) Statistical analysis
Analyses  were  conducted  using  SPSS  version  12.0  (SPSS 
inc.  Chicago,  IL).  Data  were  presented  as  means  with  stand-
ard deviation. Comparison between the groups was performed 
using  student’s  t-test.  A  p-value  less  than  0.05  was  consid-
ered  statistically  significant.
RESULTS
On  western  blot  after  the  treatment  of  the  fibroblasts  with 
TNF-α (50  pM)  for  2  days,  MMP-3  expression  in  compar-
ison to β actin was significantly lower in group I (83.9% to 
97.5%)  than  in  group  II  (99.7%  to  140.9%,  p＜0.05).  There 
was  no  inter-group  difference  in  MMP-2  expression  in  com-
parison  to  β  actin  (98.6%  to  108.9%  versus  24.3%  to 
30.4%, p＞0.05) (Fig. 1A). TGF-β1-stimulated adventitial fi-
broblasts  in  group  I  expressed  less  SM  α-actin,  SM-MHC, 
and Ki-67  than in  group  II  (SM α-actin:  100.0% to  110.6% 
in  group  I,  94.8%  to  141.6%  in  group  II,  P＜0.01; 
SM-MHC:  66.2%  to  68.5%  in  group  I,  51.9%  to  116.8%  in 
group II, p＜0.01; Ki-67: 77.1% to 72.3% in group I, 49.7% 
to 168.1% in group II, p＜0.01). SM-calponin expression was 
not  different  between  the  two  groups  (60.9%  to  143.4%  in 
group  I,  46.4%  to  144.9%  in  group  II,  p＞0.05)  (Fig.  1B). 
Presence  of  fibroblast  was  observed  on  immunofluorescence 
assay  after  more  than  6  days  of  TGF-β1  treatment  (10  pM) 
i n  g r o u p  I .  T o  t h e  c o n t r a r y ,  S M C  b e g a n  t o  a p p e a r  a f t e r  2  
days  of  TGF- β1  treatment  and  most  fibroblasts  were  trans-
f o r m e d  t o  S M C  w i t h i n  4  d a y s  i n  g r o u p  I I  ( F i g .  2 ) .
DISCUSSION
Thoracic  aortic  aneurysm  is  a  life-threatening  disease,  and 
the  pathogenesis  of  this  condition  is  attributed  to  unbearable 
wall  tension  superimposed  on  defective  aortic  wall  integrity 
and  impaired  repair  mechanisms  of  the  aortic  wall.  Cellular 
components,  such  as  endothelial  cells,  smooth  muscle  cells 
(SMCs),  inflammatory  cells,  adventitial  fibroblasts,  and  ex-
tracellular  matrix  constitute  the  aortic  wall.  Remodeling  of 
the aortic wall progresses toward the direction of maintaining 
adequate  elastance  to  meet  the  hemodynamic  requirements, 
and  impairment  of  this  remodeling  mechanism  leads  to  the 
formation  of  aortic  aneurysm,  aortic  dissection  and  rupture. 
Aortic  wall  comprises  three  layers,  and  each  layer  plays  a 
unique  role  in  coping  with  the  hydrauric  stresses.  The  endo-Adventitial Fibroblast Abormality in Thoracic Aortic Aneurysms and Aortic Dissections 
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Fig. 1. (A) The extracellular matrix metabolism was reduced in adventitial fibroblasts from the patients with TAAD. The MMP-2 expression 
in the control group was 98.6% before TNFα (50 pM) treatment and 108.9% after treatment, and 24.3% before treatment and 30.4% af-
ter treatment in the TAAD group. The MMP-3 expression in the control group enhanced from 99.7% to 140.9% and from 83.9% to 97.5% 
in the TAAD group. Thus, TNFα treated adventitial fibroblasts from TAAD aortas expressed less MMP-3 than fibroblasts from healthy 
control group. (B) The smooth muscle cell transformation was reduced in adventitial fibroblasts from the patients with TAAD. The SM α
-actin expression before TGFβ1 (10 pM) treatment in the control group was 94.8% and 141.6% after treatment, while 100.0% before 
treatment and 110.6% after treatment in the TAAD group. The SM-MHC expression in the control group was 51.9% before treatment and 
116.8% after treatment while 66.2% before treatment and 68.5% after treatment in the TAAD group. The Ki-67 expression in the control 
group was 49.7% before treatment and 168.1% after treatment, while 77.1% before treatment and 72.3% after treatment in the TAAD 
group. The SM calponin expression in the control group was 46.4% and 144.9% after treatment, while 60.9% before treatment and 
143.4% after treatment in the TAAD group. Thus, TGF-β1-stimulated adventitial fibroblasts from TAAD aortas expressed less SM α-actin 
and SM-MHC and Ki-67. Percent of controls were compared with the β actin expression. TNF=Tumor necrosis factor; MMP=Matrix metal-
loproteinase; C=Control group; TAAD=Thoracic aortic aneurysm and dissection; TGF=Transforming growth factor; SM=Smooth muscle; 
MHC=Major histocompatibility complex.
thelial  layer  prevents  the  progression  of  wall  tension  initiated 
by  the  pulsatile  blood  flow  to  the  outer  layers.  The  media, 
the middle layer, is composed of SMCs and extracellular ma-
trix (ECM). ECM consists of structural proteins, such as col-
lagen  and  elastin,  and  glue  proteins,  such  as  laminin  and 
fibronectin.  SMCs  and  ECM  determines  the  contractility  and 
distensibility  of  the  aortic  wall.  Thus,  SMCs,  collagen  and 
elastin  are  the  major  determinants  of  aortic  wall  elastance. 
Decrease  in  ECM  or  unbalance  of  the  ECM  components 
leads to stiff aortic wall, which in turn results in the develop-
ment  of  TAAD.  Decrease  in  elastin  is  reported  to  stimulate 
the  proliferation  of  the  SMCs,  and  this  disproportion  of 
SMCs and ECM is observed in the diseases aorta, which sig-
nifies  that  balanced  constitution  of  SMCs  and  ECM  is  of  ut-
most  importance  in  keeping  the  aortic  wall  integrity  [5].  The 
third and outermost layer, adventitia, incurs little tensile stress 
from the blood stream in the physiologic setting because sys-
tolic pulse energy does not reach this layer [6]. In the patho-
logic  condition  of  the  aorta,  however,  adventitial  layer  is  ac-
tively  involved  in  the  remodeling  process  by  the  production 
of  ECM,  internal  migration  of  fibroblast  with  SMC  trans-
formation,  and  angiogenesis  [7-12].  While  disruption  of  the 
endothelial layer and inflammatory cell activation leads to the 
breakdown  of  the  ECM,  SMCs  and  fibroblast  plays  an  im-
portant  role  in  maintaining  the  optimal  cell-matrix  ratio. 
To conduct a functional assessment of the adventitial fibro-
blast,  we  induced  the  degeneration  of  ECM  by  TNFα and 
measured  MMP-2,  which  degradates  collagen  IV  and  regu-
lates inflammatory process, and MMP-3, which degradates fi-
bronectin, laminin, collagens III, IV, IX, X, and cartilage pro-
teoglycan  and  regulates  healing  process  and  prevents 
artherosclerosis. On western blot, MMP-3 expression was less 
in patients with TAAD than in control group, which may sig-
nify overproduction of ECM may lead to aortic wall fibrosis. Jong Hui Suh, et al
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Fig. 2. The immunohistochemical staining after fibroblasts were exposed to TGF-β 1 (10 pM) for up to 10 days. TGF-β 1 was supple-
mented every 2 days and the expressions of fibroblast specific marker (fibroblast surface protein) and smooth muscle cell specific marker 
(SM  α  actin) were examined every 2 days. At 4
th day after treatment, the fibroblast surface protein was not expressed and SM α  actin 
was fully expressed in the control group. In TAAD group, however, the fibroblast surface protein was still expressed at 6
th day after treat-
ment (×100). Control=Normal adventitial fibroblast; TGF=Transforming growth factor; SM=Smooth muscle; TAAD=Thoracic aortic aneurysm 
and dissection.
In  the  remodeling  process,  adventitial  fibroblasts  have  a 
potential  to  be  transformed  to  SMCs  or  their  analogues  and 
to  migrate  to  the  media  [11].  To  assess  the  SMC  trans-
formation capacity of the fibroblasts, we stimulate the adven-
titial tissue with TGF- β 1 and measured SM α -actin and ac-
tin, which are contractile proteins, SM-MHC, which regulates 
basic  contraction,  SM-calponin,  which  regulates  smooth  mus-
cle  contraction,  and  Ki-67,  which  is  involved  in  SMC 
proliferation.  On  western  blot,  SM  α -actin,  SM-MHC  and 
Ki-67 decreased in patients with TAAD compared to the con-
trol  group, but  there  was  no  intergroup  difference  in  SM-cal-
ponin  level.  It  was  also  observed  that  SMC  transformation 
was  markedly  delayed  in  the  patients  with  TAAD  on  im-
munofluorescent  staining.  Thus,  adventitial  fibroblasts  main-Adventitial Fibroblast Abormality in Thoracic Aortic Aneurysms and Aortic Dissections 
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tain  aortic  wall  integrity  as  a  central  biologic  regulator,  and, 
once activated, conduct various missions such as cellular pro-
l i f e r a t i o n  a n d  E C M  p r o d u c t i o n  [11,13-19],  regulation  of  vas-
cular  tone  [20,21],  attenuation  of  oxidative  stimulus  and  in-
flammation  [22-25],  cellular  growth  [26-28],  and  cellular  mi-
gration  and  differentiation  [29,30].
CONCLUSION
In  patients  with  TAAD,  adventitial  fibroblasts  are  dysfunc-
tional  in  terms  of  decreased  ECM  production  and  impaired 
SMC transformation. Therefore, restoration of fibroblast func-
tion  may  be  the  key  to  the  prevention  and  treatment  of 
TAAD.  Further  studies  to  elucidate  the  exact  roles  of  adven-
titial  fibroblast  in  the  development  of  TAAD  are  mandatory.
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